YorkTest is a leading health and wellness company with over 40 years of expertise in food intolerance and allergy testing in the home-to-laboratory test market. The company’s aim is to empower individuals to take control of their nutrition, health and wellbeing using a range of tests covering food intolerance, allergies and health.
It is a customer centric business with consumers at the heart of the business model, the post-test aftercare, validation of tests and commitment to customer satisfaction is a number one priority.
The business has a 92% customer satisfaction rate and their offer includes personalised nutritional aftercare with every full test to ensure consumers are not left in the dark on how to put results into action. These 30-minute phone consultations look at health and current diet to help consumers replace any trigger foods with other nutritious alternatives.
As part of the transaction Richard Millman joined the Board as Non-Executive Chair. Richard is the former Managing Director of a PC World group business, part of the Dixon’s Retail Group and the former CEO of Total Fitness, the PE backed gym chain.
The UK home health diagnostic market continues to grow at speed (12- 15% growth p.a.) with an increased awareness of health, nutrition and wellbeing amongst the population. The investment from NVM is to be used to capitalise on this growth in consumer demand for at home health testing and build continued scale around YorkTest’s in-house laboratory, the most advanced tests in the market
Serving customers from an in-house ISO13485 certified manufacturing and testing laboratory
Rated Excellent on Trustpilot with a score of 4.6* Correct as at 6 July 2023
One-to-one advice provided alongside all test results
We are delighted to welcome Richard and NVM as investors in YorkTest. YorkTest is well positioned to replicate our success in the UK food intolerance and allergy testing market in the USA, having recently launched our new US ecommerce platform. At the same time, we remain the UK market leaders in food intolerance and allergy testing, whilst investing to expand our wider range of home-to-laboratory blood tests in the UKRichard Dawson , CEO , YorkTest
Under the leadership of CEO, Richard Dawson, the management team has built a robust business which is extremely well regarded in the home testing market. We are confident that with today’s investment the business is now suitability capitalised to enable the team to deliver their vision and we are delighted to be able to support them on that journey.Mauro Biagioni , Investment Partner , NVM